General Information of Drug (ID: DMTG9EV)

Drug Name
ATRC-101
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Drug Type
Antibody
Cross-matching ID
TTD ID
DO20LT

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Polyadenylate-binding protein 1 (PABPC1) TTHC8EF PABP1_HUMAN Not Available [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT04244552) A Dose Escalation Trial of ATRC-101 in Adults With Advanced Solid Malignancies. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Atreca.